漂亮101皮膚科診所

Isobornyl acrylate (IBOA) in the adhesive patch components may trigger allergy.

2,2'-methylenebis(6-tert-butyl-4-methylphenol) monoacrylate (MBPA) in the new adhesive patch components may also trigger allergy.

All suspected patients should be tested with MBPA at 0.5%, and IBOA at 0.1%.

Avoiding the use of MBPA in glucose monitoring systems should help prevent contact allergy, as it appears to be the primary sensitizer in patients with ACD to the newer Dexcom G6 Glucose Monitoring System.
.